Modified Factor VIII

Methods of treating patients with Factor VIII deficiency by administration of modified porcine factor VIII are disclosed. The particular modified porcine factor VIII is one in which most of the B domain has been removed through genetic engineering. This modified factor VIII is particularly useful for treatment of hemophiliacs, especially those undergoing bleeding episodes.

US 20,090,325,881   [MORE INFO]

Inventor(s): LOLLAR JOHN S [US]

Type of Offer: Licensing

« More Medical Patents

Share on      

CrowdSell Your Patent